Triple

T10790384
Position Surface form Disambiguated ID Type / Status
Subject White Oak, Maryland E254561 entity
Predicate isNearFederalFacility P22439 FINISHED
Object U.S. Food and Drug Administration Center for Biologics Evaluation and Research E86214 NE FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: U.S. Food and Drug Administration Center for Biologics Evaluation and Research | Statement: [White Oak, Maryland, isNearFederalFacility, U.S. Food and Drug Administration Center for Biologics Evaluation and Research]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: U.S. Food and Drug Administration Center for Biologics Evaluation and Research
Context triple: [White Oak, Maryland, isNearFederalFacility, U.S. Food and Drug Administration Center for Biologics Evaluation and Research]
  • A. Center for Biologics Evaluation and Research chosen
    The Center for Biologics Evaluation and Research is the U.S. regulatory body responsible for overseeing the safety, efficacy, and quality of biological products such as vaccines, blood products, and gene therapies.
  • B. Center for Drug Evaluation and Research
    The Center for Drug Evaluation and Research is the U.S. FDA division responsible for overseeing the safety, effectiveness, and quality of prescription and over-the-counter drugs.
  • C. Office of Compliance and Biologics Quality
    The Office of Compliance and Biologics Quality is a division within the FDA’s biologics center responsible for ensuring the safety, quality, and regulatory compliance of biological products such as vaccines, blood, and cellular therapies.
  • D. Center for Devices and Radiological Health
    The Center for Devices and Radiological Health is the U.S. FDA division responsible for regulating medical devices and radiation-emitting products to ensure their safety and effectiveness.
  • E. Food and Drug Administration
    The Food and Drug Administration is a U.S. federal agency responsible for protecting public health by regulating food, drugs, medical devices, and other consumer products.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d6aa609f008190a294200aefcb7bd5 completed April 8, 2026, 7:20 p.m.
NER Named-entity recognition batch_69d732f5b8248190a633dc44ae620a3a completed April 9, 2026, 5:02 a.m.
NED1 Entity disambiguation (via context triple) batch_69de562873b081908bea08c56b1c1e3f completed April 14, 2026, 2:58 p.m.
Created at: April 8, 2026, 9:17 p.m.